DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed ...
Atrial fibrillation (irregular heartbeat), which causes poor blood flow, is another cardiovascular condition that can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback